You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

SU011248

Showing 1 - 25 of 105
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thymic Carcinoma Trial in Columbus (other, biological, drug)

Recruiting
  • Thymic Carcinoma
  • Laboratory Biomarker Analysis
  • +2 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Apr 27, 2022

Renal Cell Carcinoma Trial in Houston (Sunitinib, Nephrectomy)

Active, not recruiting
  • Renal Cell Carcinoma
  • Houston, Texas
  • +1 more
Oct 11, 2022

Paraganglioma, Pheochromocytoma Trial in Canada, Netherlands (Sunitinib)

Active, not recruiting
  • Paraganglioma
  • Pheochromocytoma
  • Calgary, Alberta, Canada
  • +3 more
Nov 29, 2021

Metastatic Pancreatic Neuroendocrine Tumor, Pancreatic Tumor, Stage III Pancreatic Neuroendocrine Tumor AJCC v8 Trial

Not yet recruiting
  • Metastatic Pancreatic Neuroendocrine Tumor
  • +4 more
  • Biospecimen Collection
  • +5 more
  • (no location specified)
Jan 14, 2023

Papillary Thyroid Cancer, Follicular Thyroid Cancer, Differentiated Thyroid Cancer Trial in Washington (SU011248, Sutent)

Completed
Has Results
  • Papillary Thyroid Cancer
  • +2 more
  • SU011248, Sutent
  • Washington, District of Columbia
    MedStar Washington Hospital Center
Aug 3, 2020

Advanced Cancer Trial in Houston (Bevacizumab, Sorafenib, Erlotinib)

Completed
  • Advanced Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Jun 27, 2020

Kidney Cancer Trial in United States (Gemcitabine, Sunitinib)

Completed
Has Results
  • Kidney Cancer
  • Birmingham, Alabama
  • +98 more
Dec 29, 2021

Sarcoma, Soft Tissue Trial in New York (Sunitinib)

Terminated
Has Results
  • Sarcoma, Soft Tissue
  • New York, New York
    Columbia University Medical Center
Oct 15, 2019

Non Small Cell Lung Cancer Trial in Madison (erlotinib, sunitinib)

Completed
  • Non Small Cell Lung Cancer
  • erlotinib, sunitinib
  • Madison, Wisconsin
    University of Wisconsin Carbone Comprehensive Cancer Center
Nov 15, 2019

Magnetic Resonance Imaging in Predicting Response to Sunitinib

Completed
  • Renal Cell Carcinoma
  • +2 more
  • mutation analysis
  • +5 more
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of The University of Pennsylvania
Jun 21, 2019

Recurrent Bladder Cancer, Transitional Cell Carcinoma of the Bladder Trial in Cleveland (sunitinib malate, immunohistochemistry

Terminated
Has Results
  • Recurrent Bladder Cancer
  • Transitional Cell Carcinoma of the Bladder
  • sunitinib malate
  • +4 more
  • Cleveland, Ohio
  • +1 more
Apr 17, 2019

Recurrent Non-Small Cell Lung Carcinoma, Stage IIIB NSCLC AJCC v7, Stage IV NSCLC AJCC v7 Trial in United States (Laboratory

Completed
Has Results
  • Recurrent Non-Small Cell Lung Carcinoma
  • +2 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Anaheim, California
  • +128 more
Jan 13, 2022

Endometrial Adenocarcinoma, Endometrial Endometrioid Adenocarcinoma, Endometrial Serous Adenocarcinoma Trial in Canada, United

Completed
Has Results
  • Endometrial Adenocarcinoma
  • +7 more
  • Sunitinib Malate
  • Beverly Hills, California
  • +28 more
Feb 14, 2020

Urothelial Cancer, Bladder Cancer, Adult Trial in Canada (SU011248, Placebo)

Completed
  • Urothelial Cancer
  • +2 more
  • SU011248
  • Placebo
  • Calgary, Alberta, Canada
  • +4 more
Aug 20, 2018

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Portland (drug, device, biological)

Completed
  • Acute Lymphoblastic Leukemia
  • Acute Myeloid Leukemia
  • Portland, Oregon
    OHSU Knight Cancer Institute
May 21, 2020

Clear Cell Renal Cell Carcinoma, Stage IV Renal Cell Cancer Trial in Cleveland (sunitinib malate)

Completed
Has Results
  • Clear Cell Renal Cell Carcinoma
  • Stage IV Renal Cell Cancer
  • sunitinib malate
  • Cleveland, Ohio
    Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
Aug 17, 2018

Well-differentiated Pancreatic Neuroendocrine Tumor Trial in Worldwide (sunitinib)

Completed
Has Results
  • Well-differentiated Pancreatic Neuroendocrine Tumor
  • Orange, California
  • +25 more
Jul 22, 2019

Lung Cancer Trial in Amsterdam (drug, other, radiation)

Terminated
  • Lung Cancer
  • sunitinib malate
  • +2 more
  • Amsterdam, Netherlands
    Vrije Universiteit Medisch Centrum
Jul 25, 2018

Ovarian Clear Cell Adenocarcinoma, Recurrent Ovarian Carcinoma Trial in Korea, Republic of, United States (Laboratory Biomarker

Completed
Has Results
  • Ovarian Clear Cell Adenocarcinoma
  • Recurrent Ovarian Carcinoma
  • Laboratory Biomarker Analysis
  • Sunitinib Malate
  • Birmingham, Alabama
  • +96 more
Feb 6, 2020

Extensive Stage Lung Small Cell Carcinoma, Recurrent Lung Small Cell Carcinoma Trial in United States (Carboplatin, Cisplatin,

Completed
Has Results
  • Extensive Stage Lung Small Cell Carcinoma
  • Recurrent Lung Small Cell Carcinoma
  • Arroyo Grande, California
  • +124 more
Apr 14, 2020

Locally Advanced Papillary Renal Cell Carcinoma, Metastatic Papillary Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v7

Active, not recruiting
Has Results
  • Locally Advanced Papillary Renal Cell Carcinoma
  • +6 more
  • Cabozantinib S-malate
  • +3 more
  • Anchorage, Alaska
  • +596 more
Aug 2, 2022

Clear Cell Renal Cell Carcinoma, Metastatic Kidney Carcinoma, Stage III Renal Cell Cancer AJCC v7 Trial in United States

Completed
Has Results
  • Clear Cell Renal Cell Carcinoma
  • +3 more
  • Cabozantinib S-malate
  • +2 more
  • Mobile, Alabama
  • +487 more
Jan 28, 2021

Adult Solid Tumor, Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Carcinoma Trial in Madison (Computed Tomography,

Completed
  • Adult Solid Neoplasm
  • +4 more
  • Computed Tomography
  • +5 more
  • Madison, Wisconsin
    University of Wisconsin Hospital and Clinics
Oct 9, 2017

Metastatic Breast Cancer, Advanced Breast Cancer, Metastatic Castration Resistant Prostate Cancer Trial in Worldwide (sunitinib)

Completed
Has Results
  • Metastatic Breast Cancer
  • +11 more
  • Atlanta, Georgia
  • +112 more
Jun 20, 2019

Esophageal Cancer Trial in Columbus (sunitinib malate)

Completed
Has Results
  • Esophageal Cancer
  • sunitinib malate
  • Columbus, Ohio
    Ohio State University Medical Center
Jan 31, 2017